1-10 of 10
Sushmitha Nanja Reddy
Close
Sort by
Journal Articles

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 4321.
https://doi.org/10.1182/blood-2023-191331
Published: 2023
Journal Articles

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Lakshmi Bhavani Potluri, Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Dakshin Padmanabhan, Gregory Dyson, Julie Boerner, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 1853.
https://doi.org/10.1182/blood-2023-191277
Published: 2023
Journal Articles

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Gregory Dyson, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 822.
https://doi.org/10.1182/blood-2023-191336
Published: 2023
Journal Articles

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Jeff Aguilar, Vikram Dhillon, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Julie Boerner, Gregory Dyson, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 6445.
https://doi.org/10.1182/blood-2023-190854
Published: 2023
Journal Articles

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Sushmitha Nanja Reddy, Jeff Aguilar, Lakshmi Bhavani Potluri, Vikram Dhillon, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian, Julie Boerner, Gregory Dyson
Journal: Blood
Blood (2023) 142 (Supplement 1): 6447.
https://doi.org/10.1182/blood-2023-189972
Published: 2023
Journal Articles

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Dakshin Padmanabhan, Jeff Aguilar, Gregory Dyson, Lakshmi Bhavani Potluri, Vikram Dhillon, Sushmitha Nanja Reddy, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 6013.
https://doi.org/10.1182/blood-2023-190860
Published: 2023
Journal Articles

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

Ali Al Sbihi, Sushmitha Nanja Reddy, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Abdul Moiz Khan, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6189–6190.
https://doi.org/10.1182/blood-2022-171131
Published: 2022
Journal Articles

Recurrent KMT2C Mutations As Clonal Hematopoiesis Is Common after Chemotherapy Exposure in Hodgkin's Lymphoma Patients

Sushmitha Nanja Reddy, Abdul Moiz Khan, Vikram Dhillon, Ali Al Sbihi, Amanda Tear, Breanna William, Sonubar Virk, Julie Boerner, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6584–6585.
https://doi.org/10.1182/blood-2022-170971
Published: 2022
Journal Articles

Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia

Vikram Dhillon, Abdul Moiz Khan, Ali Al Sbihi, Sushmitha Nanja Reddy, Enxhi Lalo, Harry Ramos, Jay Yang, Anupama Kottam, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6183–6184.
https://doi.org/10.1182/blood-2022-169932
Published: 2022
Journal Articles

Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia

Abdul Moiz Khan, Sushmitha Nanja Reddy, Mai M M Aly, Vikram Dhillon, Ali Al Sbihi, Tariq Kewan, Waled Bahaj, Carmelo Gurnari, Bayan Al-Share, Gregory Dyson, Valeria Visconte, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 1433–1434.
https://doi.org/10.1182/blood-2022-165696
Published: 2022